Skip to content

Lilly’s tirzepatide cuts heart failure risks, company says

  • by
Spread the love

 NBC News Top StoriesEli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with obesity, the company said Thursday.

​Eli Lilly’s drug tirzepatide, sold under the names Mounjaro for diabetes and Zepbound for weight loss, improved symptoms in heart failure patients with obesity, the company said Thursday.  

Read More

Leave a Reply

Your email address will not be published. Required fields are marked *